These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27503751)

  • 1. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography.
    Abbattista T; Ridolfi F; Consalvo GT; Brunelli E
    J Ultrasound Med; 2016 Oct; 35(10):2121-8. PubMed ID: 27503751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography.
    Abbattista T; Ridolfi F; Ciabattoni E; Marini F; Bendia E; Brunelli E; Busilacchi P
    Radiol Med; 2008 Sep; 113(6):860-74. PubMed ID: 18587531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent.
    Albrecht T; Blomley MJ; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; Patel N
    Lancet; 1999 May; 353(9164):1579-83. PubMed ID: 10334257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
    Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
    Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of hepatic vein arrival time performed with contrast-enhanced ultrasonography for HCV liver cirrhosis.
    Makhlouf NA; Moustafa EF; Hassany SM
    Arab J Gastroenterol; 2022 Aug; 23(3):195-200. PubMed ID: 35688684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C.
    Ridolfi F; Abbattista T; Marini F; Vedovelli A; Quagliarini P; Busilacchi P; Brunelli E
    Dig Liver Dis; 2007 Oct; 39(10):929-35. PubMed ID: 17669702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of contrast-enhanced ultrasound in evaluating portal hypertension in patients with decompensated liver cirrhosis].
    Zhuang Y; Ding H; Han H; Mao F; Luo JJ; Chen SY; Wang WP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):270-4. PubMed ID: 27470625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute outflow obstruction of hepatic veins in rabbits: quantitative analysis of hepatic perfusion with contrast-enhanced sonography.
    Kim KW; Kim PN; Shin JH; Shin DH; Jeong WK; Won HJ; Shin YM; Lee WJ; Lee MG; Song GW; Hwang S; Lee SG
    J Ultrasound Med; 2011 May; 30(5):635-42. PubMed ID: 21527611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Arrival Time Difference Between Lesions and Lung Tissue on Contrast-Enhanced Sonography in the Differential Diagnosis of Subpleural Pulmonary Lesions.
    Bai J; Yang W; Wang S; Guan RH; Zhang H; Fu JJ; Wu W; Yan K
    J Ultrasound Med; 2016 Jul; 35(7):1523-32. PubMed ID: 27246663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis.
    Sugimoto H; Kaneko T; Hirota M; Tezel E; Nakao A
    J Hepatol; 2002 Nov; 37(5):578-83. PubMed ID: 12399222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease.
    Pedersen JF; Larsen VA; Bytzer P; Madsen LG; Hamberg O
    Acta Radiol; 2005 Oct; 46(6):557-60. PubMed ID: 16334835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic transit times and liver elasticity compared with meld in predicting a 1 year adverse clinical outcome of a clinically diagnosed cirrhosis].
    Koller T; Piešťanská Z; Hlavatý T; Holomáň J; Glasa J; Payer J
    Vnitr Lek; 2016; 62(5):351-9. PubMed ID: 27319227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography.
    Ishibashi H; Maruyama H; Takahashi M; Fujiwara K; Imazeki F; Yokosuka O
    Liver Int; 2010 Oct; 30(9):1355-63. PubMed ID: 20704652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative diagnosis of early-stage liver cirrhosis with contrast-enhanced ultrasound--a clinical study.
    Shi Y; Wang XH; Xia GC; Lei CG
    Adv Clin Exp Med; 2012; 21(3):385-90. PubMed ID: 23214202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.
    Kim MY; Suk KT; Baik SK; Kim HA; Kim YJ; Cha SH; Kwak HR; Cho MY; Park HJ; Jeon HK; Park SY; Kim BR; Hong JH; Jo KW; Kim JW; Kim HS; Kwon SO; Chang SJ; Baik GH; Kim DJ
    Hepatology; 2012 Sep; 56(3):1053-62. PubMed ID: 22473911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
    Nasr P; Hilliges A; Thorelius L; Kechagias S; Ekstedt M
    Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.
    Lim AK; Taylor-Robinson SD; Patel N; Eckersley RJ; Goldin RD; Hamilton G; Foster GR; Thomas HC; Cosgrove DO; Blomley MJ
    Gut; 2005 Jan; 54(1):128-33. PubMed ID: 15591518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic perfusion parameters of contrast-enhanced ultrasonography correlate with the severity of chronic liver disease.
    Liu D; Qian L; Wang J; Hu X; Qiu L
    Ultrasound Med Biol; 2014 Nov; 40(11):2556-63. PubMed ID: 25218453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
    Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
    AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound.
    Gauthier TP; Wasan HS; Muhammad A; Owen DR; Leen EL
    J Ultrasound Med; 2011 Mar; 30(3):379-85. PubMed ID: 21357560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.